research2guidance - Interview with Henro van Rooyen, Regional Lead, EMEA, TrialScreen
Patient recruitment and retention remain critical bottlenecks in clinical research, causing delays in the majority of trials and driving up| research2guidance
Patient recruitment and retention remain critical bottlenecks in clinical research, causing delays in the majority of trials and driving up| research2guidance
R2G Connect launched a dedicated Longevity Pitching Event, giving startups direct access to investors who are actively shaping| research2guidance
HealthTech is a repeat player’s game at least at first glance. What do the numbers say about the long-term performance of serial founders| research2guidance
Most hospitals are not tapping into this opportunity. Despite having world-class clinical knowledge, experienced medical and administrative teams,| research2guidance
